Helping you make wiser investment decisions

Pharmaceuticals, health and wellness

Big Pharma grounds employees: GSK, Bristol, Roche, Sanofi and more limit travel due to coronavirus

Biopharma companies are hunkering down as the COVID-19 epidemic breaks out worldwide. In a FiercePharma survey of biopharma companies late last month, most drugmakers said they were simply limiting travel to hard-hit countries such as China, South Korea and Italy. Now, as more cases pop up across the U.S., Europe and Asia, their tone has shifted. GlaxoSmithKline has “instructed all employees […]

AstraZeneca’s Imfinzi records double bladder cancer failure, endangering first nod and dual-IO case

It’s one of those trials that bear some weight: It was meant to confirm a med’s first-ever approval, and industry watchers were looking for clues to assess the chance of future success. But in the case of AstraZeneca’s Imfinzi in bladder cancer, the immunotherapy has failed. On Friday, AstraZeneca said Imfinzi, given alone and in […]

Biogen cracks down on travel after 3 execs test positive for coronavirus

The novel coronavirus has hit home at Biogen, where three executives who traveled to a headquarters management meeting have tested positive for the illness. At last week’s meeting, a “number of attendees reported varying degrees of flu-like symptoms,” the company said in a statement reported in numerous publications. Some have confirmed influenza, while, so far, three […]

Hikma halts production of pain drug because of ‘gelatinous particles’ in vials

Hikma’s U.S. operation has stopped production of an injected pain drug as it figures out how to fix an issue that has resulted in black, oily and gelatinous particles in some vials of the drug. The drugmaker made the disclosure as it extended its recall to the retailer and medical facilities.  The voluntary recall of […]

Pfizer adds Coca-Cola, GE vets to board to help navigate post-Upjohn growth

Pfizer and Mylan, nearing the finish line on their planned generics megamerger, have shuffled their leadership teams in anticipation of the new company coming online. After announcing it would move two of its directors into leadership roles at the merger, Pfizer is bringing on two corporate vets to help lead during a period analysts say could be […]

Eli Lilly says its drug supply, including insulins, are safe from COVID-19 for now 

Eli Lilly, one of the major producers of insulin for the U.S., reassured consumers and the market today, saying it does not expect any shortages of its products as the COVID-19 outbreak spreads around the world.   It pointed out that it does not get the active pharmaceutical ingredients for any of its approved medicines from China, […]

Testing lab challenges FDA findings that carcinogens in metformin do not exceed acceptable levels

As questions about suspected carcinogens in drugs continue to roil the supply chain, the FDA last month said its testing of metformin did not find any with unacceptably high levels of NDMA. But testing laboratory Valisure has challenged those findings in a new Public Citizen petition, saying it discovered problems in 42% of the batches […]

Former Sanofi CEO Brandicourt takes board seat at RNAi therapy maker Alnylam

When former Sanofi CEO Olivier Brandicourt handed the reins to Paul Hudson in June, it marked a turning point after a tumultuous period at the French drugmaker. Now eight months out of a job, Brandicourt is now taking a boardroom seat at a much younger drugmaker with the opportunity for big growth in the coming […]

Drugmakers tell analyst ingredient prices are rising as FDA reports first supply hit tied to COVID-19

The world’s heavy reliance on cheap Chinese ingredients has shown a fault line in the U.S., as the FDA reports the first shortage of a drug due to the COVID-19 outbreak. With 20 other FDA approved drugs relying solely on China as the source of an API or finished product, more shortages may soon materialize. […]

Biohaven set to take on Allergan, Lilly with new migraine med and 500-plus reps

With a new FDA nod for migraine medicine Nurtec ODT, Biohaven will be going up against serious marketing muscle from Allergan and Eli Lilly. But the company is optimistic about its rollout thanks to an “unbelievable” label and a sales team of more 500 reps, execs said Friday.  Formerly known as rimegepant, Nurtec ODT is a dissolvable oral medication that offers migraine sufferers “early and sustained efficacy,” Biohaven’s neurology […]

Pfizer, Mylan vets tapped for Viatris board, C-suite as merger nears

With the board appointments of former leaders at Pfizer and Mylan, generics megamerger Viatris has already indicated its predecessors would play an outsized leadership role. Now, with nine more Pfizer and Mylan board members moving over––and a Pfizer CFO, to boot––the past is definitively the future at Viatris.  Viatris has fleshed out its 13-member board of […]

Amarin aims for Vascepa boom with doubled sales force nearly in place

Amarin scored an FDA win with blockbuster potential last year when its fish oil-derivative Vascepa received a heart-helping nod on top of statins. Now, with Amarin’s fleshed out sales force nearly in place and prescriptions soaring, the drugmaker is ready to take Vascepa to the next level.  Amarin closed 2019 with a whopping 87% increase […]